In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...
People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...
23h
MedPage Today on MSNApproved Sickle Cell Drug Fails to Beat Placebo in TrialCrizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on March 13 and set a price target of ...
13h
Sportcal on MSNNovartis in as first NFL pharmaceutical sponsorAmerican football’s elite National Football League (NFL) has brought in US medicine company Novartis as the property's ...
Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...
Recent health news highlights include Apollo Hospitals' investment in AI for staff workload management, controversies ...
ALNY stock soars 62% in a year, driven by increasing Amvuttra and Givlaari sales. Its ongoing collaboration deals with RHHBY, NVS and REGN are progressing well.
Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...
Poor physical function correlated with outcomes among patients with non-Hodgkin lymphoma who underwent chimeric antigen receptor T-cell therapy, according to results of a retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results